MADISON, Wis.--(BUSINESS WIRE)--

Nine Wisconsin biotechnology companies have been awarded scholarships to support attending the Biotechnology Industry Organizations (BIO) International Convention in Boston, MA. June 18-21, 2012. All recipients plan to participate in BIOs one-on-one partnering with potential customers from around the world, or to present to potential investors.

The grant fund was assembled by BioForward, and includes funds provided by Wisconsin Economic Development Corporation and Marshfield Clinic Applied Sciences. Scholarship recipients are small biotechnology businesses that demonstrate a strategic approach to the Business Forum, and have a financial need.

The scholarship recipients are:

Centrose preclinical stage company developing a novel antibody-drug conjugation technology that targets a wide variety of diseased cells.

DNASTAR company focused primarily on developing and commercializing software for scientists working with DNA sequence analysis.

InvivoSciences - contract research organization providing engineered tissue-based phenotypic compound screening services for pharmaceutical, cosmetic, biotech, food, and chemical companies.

NeoClone company designing and manufacturing monoclonal antibodies, for their ability to seek out and bind to a specific target such as a virus, toxin, bacterium or tumor cell.

Primorigen company developing innovative high-throughput protein and cell-based assay systems and novel stem cell biology research products.

Quintessence Biosciences private, clinical stage biopharmaceutical company developing novel anti-cancer compounds based on patented EVade Ribonuclease technology.

See the article here:
9 Small Businesses Awarded Scholarships to Attend International BIO Convention